Background: Allergy evaluation and skin prick testing for foods are recommended in all patients with eosinophilic esophagitis. However, the yield of allergy evaluation in adult eosinophilic esophagitis is not known.
Goals: To determine the yield of allergy evaluation in adults with eosinophilic esophagitis.
Study: All adult patients in the Cleveland Clinic eosinophilic esophagitis registry between January 2006 and April 2008 were identified. Diagnosis was based on clinical presentation and endoscopy with biopsies showing > or = 15 eosinophils/hpf. From this group, all patients referred for allergy evaluation were identified. Allergy evaluation consisted of skin testing to foods in all patients. Selected patients underwent skin testing to inhalants based on the presence of concomitant allergic rhinitis and/or asthma. Immediate hypersensitivity skin testing was performed and scored by standard methodology. Patients were referred on an ad hoc basis by the gastroenterologist and not based on a priori identification of an allergic diathesis.
Results: Twenty-six out of 68 patients (38%) completed allergy evaluation. Thirteen out of 26 patients (50%) demonstrated a positive skin test to > or = 1 food allergen. Of the 15 patients who underwent skin testing for inhalants, 14 (93%) had a positive skin test to 1 or more inhalants. In total 21/26 patients (81%) had > or = 1 allergen identified, 16/26 (62%) had > or = 5 allergens identified, and 4/26 (15%) had > or = 10 allergens identified (range: 0 to 20 allergens identified). Peanut, egg white, soybean, cow's milk, and tree nuts were the most common food allergens identified.
Conclusions: Allergy evaluation has a high yield in adult eosinophilic esophagitis as 81% of referred patients had one or more allergens identified and 50% had one or more skin tests positive to foods. Allergy evaluation should be considered in adult patients with eosinophilic esophagitis.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MCG.0b013e3181a1bee5 | DOI Listing |
Int J Clin Pharm
January 2025
Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Background: Few studies have examined the use of self-screening tools and patient alert cards (PAC) for screening adverse drug reactions (ADRs).
Aim: To evaluate the benefits of self-screening tools and PAC for screening ADRs.
Method: A prospective study of outpatients was conducted at a tertiary care teaching hospital.
Int J Cancer
January 2025
Department of Neurosurgery, LMU University Hospital, Munich, Germany.
Neurologic immune-related adverse events (nirAEs) represent rare, yet severe side effects associated with immune checkpoint inhibitor (ICI) therapy. Given the absence of established diagnostic biomarkers for nirAEs, we aimed to evaluate the diagnostic utility of serum Neurofilament Light Chain (NfL) and Glial Fibrillary Acidic Protein (GFAP). Fifty-three patients were included at three comprehensive cancer centers, of these 20 patients with manifest nirAEs and 11 patients with irHypophysitis.
View Article and Find Full Text PDFTransl Lung Cancer Res
December 2024
Department of Biomedical Engineering, Gachon University, Seongnam, Republic of Korea.
Lung cancer is a malignant tumor with high incidence and mortality rates in both men and women worldwide. Although anticancer drugs are prescribed to treat lung cancer patients, individual responses to these drugs vary, making it crucial to identify the most suitable treatment for each patient. Therefore, it is necessary to develop an anticancer drug efficacy prediction model that can analyze drug efficacy before patient treatment and establish personalized treatment strategies.
View Article and Find Full Text PDFBackground: HIV acquisition among adolescents and young adults (AYA, 15-24 years) is influenced by individual factors, community factors, and public policies and programs. We explored the association of HIV incidence and prevalence with these factors over time among AYA in Rakai, Uganda.
Methods: We examined trends over nine survey rounds (2005-2020) of the Rakai Community Cohort Study (RCCS), an open population-based surveillance cohort of individuals living in 30 continuously followed communities in south-central Uganda (n= 35,938 person rounds).
World Allergy Organ J
January 2025
Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.
Background: This study aimed to evaluate the impact of severe asthma (SA) treatments after 12 months in achieving clinical remission (CR) within the context of the Severe Asthma Network in Italy (SANI) using the recent SANI definition of CR on treatment.
Methods: CR has been defined by SANI as complete, partial, and no CR. Complete CR is defined by the absence of oral corticosteroids (OCS), no symptoms, no exacerbations, and stable lung function, and partial CR requires the absence of OCS and the fulfillment of 2 out of the other 3 criteria.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!